학술논문

Intravitreal connective tissue growth factor neutralizing antibody or bevacizumab alone or in combination for prevention of proliferative vitreoretinopathy in an experimental model
Document Type
Journal
Source
EXPERIMENTAL EYE RESEARCH; JUL 2021, 208 p108622 10p.
Subject
Language
English
ISSN
10960007